The enrichment of cyclin D1-regulated G1 events (Table S6C) and G1 cell cycle transition (Figs. S9, S13) in Metabric-DEGs supports an important role of CYB5D2 downregulation in BC pathogenesis. Here, CYB5D2 is linked to breast cancer.